# Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

> **NCT03314974** · PHASE2 · RECRUITING · sponsor: **Masonic Cancer Center, University of Minnesota** · enrollment: 300 (estimated)

## Conditions studied

- Acute Leukemia
- Acute Myeloid Leukemia
- Acute Lymphoblastic Leukemia
- Lymphoma
- Chronic Myelogenous Leukemia
- Plasma Cell Leukemia
- Myeloproliferative Neoplasms
- Myelofibrosis
- Myelodysplasia
- Refractory Anemia
- High Risk Anemia
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Marginal Zone B-Cell Lymphoma
- Follicular Lymphoma
- Lymphoplasmacytic Lymphoma
- Mantle-Cell Lymphoma
- Prolymphocytic Leukemia
- Diffuse Large Cell Non Hodgkins Lymphoma
- Lymphoblastic Lymphoma
- Burkitt Lymphoma
- High Grade Non-Hodgkin's Lymphoma, Adult
- Multiple Myeloma
- Juvenile Myelomonocytic Leukemia
- Biphenotypic/Undifferentiated/Prolymphocytic Leukemias
- MRD Positive Leukemia
- Natural Killer Cell Malignancies
- Acquired Bone Marrow Failure Syndromes

## Interventions

- **BIOLOGICAL:** HSCT with TBI Regimen
- **BIOLOGICAL:** HSCT with Non-TBI Regimen

## Key facts

- **NCT ID:** NCT03314974
- **Lead sponsor:** Masonic Cancer Center, University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-03-30
- **Primary completion:** 2026-06-10
- **Final completion:** 2027-06-10
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03314974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03314974, "Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03314974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*